0001885827 2026-07-23 2026-07-23 0001885827 1 2026-07-23 2026-07-23 0001885827 2 2026-07-23 2026-07-23 iso4217:USD pure shares F-3 F-3 EX-FILING FEES 0001885827 Virax Biolabs Group Ltd N/A N/A F-3 Virax Biolabs Group Ltd false Equity Ordinary Shares issuable upon exercise of Series A Preferred Investment Options and Series B Preferred Investment Options true 1644000 6.00 9864000.00 0.0001381 1362.22 false Equity Ordinary Shares issuable upon exercise of Placement Agent Warrants true 38360 7.50 287700.00 0.0001381 39.73 10151700.00 1401.95 0.00 0.00 1401.95 (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers any additional ordinary shares that may become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration. (2) Pursuant to Rule 457(g) under the Securities Act, the proposed maximum offering price per share is based on the exercise price of the Preferred Investment Options, which is $6.00 per share. (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers any additional ordinary shares that may become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration. (3) Pursuant to Rule 457(g) under the Securities Act, the proposed maximum offering price per share is based on the exercise price of the Placement Agent Warrants, which is $7.50 per share.